Global Long-acting GLP-1RA Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Long-acting GLP-1RA market size was valued at US$ 17220 million in 2022. With growing demand in downstream market, the Long-acting GLP-1RA is forecast to a readjusted size of US$ 29090 million by 2029 with a CAGR of 7.8% during review period.
The research report highlights the growth potential of the global Long-acting GLP-1RA market. Long-acting GLP-1RA are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Long-acting GLP-1RA. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Long-acting GLP-1RA market.
A long-acting GLP-1RA, or Long-acting Glucagon-Like Peptide-1 Receptor Agonist, is a medication designed for the treatment of type 2 diabetes and, in some cases, obesity. It is characterized by an extended half-life, typically requiring only once-weekly injections. Long-acting GLP-1RAs have the ability to enhance insulin secretion from the pancreas and reduce the release of glucagon, thereby lowering post-meal blood sugar levels. Furthermore, they are effective at reducing fasting blood sugar levels and have a more pronounced effect on weight loss.
Long-acting GLP-1RA (Glucagon-Like Peptide-1 Receptor Agonist) is experiencing rapid growth in the diabetes treatment sector. The market size is continually expanding, with increasing sales demonstrating its significant potential. Long-acting GLP-1RA medications are favored for their unique effects in improving blood sugar control while aiding in weight reduction, gradually becoming a mainstream choice for type 2 diabetes treatment. Beyond glucose regulation, their specific uses extend to assisting patients in achieving weight management goals. In the future, long-acting GLP-1RA is poised to optimize formulations, mitigate side effects, and broaden its reach to a more diverse patient population, offering more effective and personalized treatment options for diabetes patients worldwide.
Key Features:
The report on Long-acting GLP-1RA market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Long-acting GLP-1RA market. It may include historical data, market segmentation by Type (e.g., Liraglutide, Albiglutide), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Long-acting GLP-1RA market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Long-acting GLP-1RA market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Long-acting GLP-1RA industry. This include advancements in Long-acting GLP-1RA technology, Long-acting GLP-1RA new entrants, Long-acting GLP-1RA new investment, and other innovations that are shaping the future of Long-acting GLP-1RA.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Long-acting GLP-1RA market. It includes factors influencing customer ' purchasing decisions, preferences for Long-acting GLP-1RA product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Long-acting GLP-1RA market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Long-acting GLP-1RA market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Long-acting GLP-1RA market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Long-acting GLP-1RA industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Long-acting GLP-1RA market.
Market Segmentation:
Long-acting GLP-1RA market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Long-acting GLP-1RA market?
What factors are driving Long-acting GLP-1RA market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-acting GLP-1RA market opportunities vary by end market size?
How does Long-acting GLP-1RA break out type, application?
According to our LPI (LP Information) latest study, the global Long-acting GLP-1RA market size was valued at US$ 17220 million in 2022. With growing demand in downstream market, the Long-acting GLP-1RA is forecast to a readjusted size of US$ 29090 million by 2029 with a CAGR of 7.8% during review period.
The research report highlights the growth potential of the global Long-acting GLP-1RA market. Long-acting GLP-1RA are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Long-acting GLP-1RA. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Long-acting GLP-1RA market.
A long-acting GLP-1RA, or Long-acting Glucagon-Like Peptide-1 Receptor Agonist, is a medication designed for the treatment of type 2 diabetes and, in some cases, obesity. It is characterized by an extended half-life, typically requiring only once-weekly injections. Long-acting GLP-1RAs have the ability to enhance insulin secretion from the pancreas and reduce the release of glucagon, thereby lowering post-meal blood sugar levels. Furthermore, they are effective at reducing fasting blood sugar levels and have a more pronounced effect on weight loss.
Long-acting GLP-1RA (Glucagon-Like Peptide-1 Receptor Agonist) is experiencing rapid growth in the diabetes treatment sector. The market size is continually expanding, with increasing sales demonstrating its significant potential. Long-acting GLP-1RA medications are favored for their unique effects in improving blood sugar control while aiding in weight reduction, gradually becoming a mainstream choice for type 2 diabetes treatment. Beyond glucose regulation, their specific uses extend to assisting patients in achieving weight management goals. In the future, long-acting GLP-1RA is poised to optimize formulations, mitigate side effects, and broaden its reach to a more diverse patient population, offering more effective and personalized treatment options for diabetes patients worldwide.
Key Features:
The report on Long-acting GLP-1RA market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Long-acting GLP-1RA market. It may include historical data, market segmentation by Type (e.g., Liraglutide, Albiglutide), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Long-acting GLP-1RA market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Long-acting GLP-1RA market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Long-acting GLP-1RA industry. This include advancements in Long-acting GLP-1RA technology, Long-acting GLP-1RA new entrants, Long-acting GLP-1RA new investment, and other innovations that are shaping the future of Long-acting GLP-1RA.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Long-acting GLP-1RA market. It includes factors influencing customer ' purchasing decisions, preferences for Long-acting GLP-1RA product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Long-acting GLP-1RA market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Long-acting GLP-1RA market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Long-acting GLP-1RA market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Long-acting GLP-1RA industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Long-acting GLP-1RA market.
Market Segmentation:
Long-acting GLP-1RA market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Liraglutide
- Albiglutide
- Dulaglutide
- Semaglutide
- Polyethylene Glycol Loxenatide
- Exenatide Microspheres
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- GSK
- Novo Nordisk
- AstraZeneca
- Eli Lily
- Hansoh Pharmaceutical
What is the 10-year outlook for the global Long-acting GLP-1RA market?
What factors are driving Long-acting GLP-1RA market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-acting GLP-1RA market opportunities vary by end market size?
How does Long-acting GLP-1RA break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting GLP-1RA Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Long-acting GLP-1RA by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Long-acting GLP-1RA by Country/Region, 2018, 2022 & 2029
2.2 Long-acting GLP-1RA Segment by Type
2.2.1 Liraglutide
2.2.2 Albiglutide
2.2.3 Dulaglutide
2.2.4 Semaglutide
2.2.5 Polyethylene Glycol Loxenatide
2.2.6 Exenatide Microspheres
2.3 Long-acting GLP-1RA Sales by Type
2.3.1 Global Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
2.3.2 Global Long-acting GLP-1RA Revenue and Market Share by Type (2018-2023)
2.3.3 Global Long-acting GLP-1RA Sale Price by Type (2018-2023)
2.4 Long-acting GLP-1RA Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Long-acting GLP-1RA Sales by Application
2.5.1 Global Long-acting GLP-1RA Sale Market Share by Application (2018-2023)
2.5.2 Global Long-acting GLP-1RA Revenue and Market Share by Application (2018-2023)
2.5.3 Global Long-acting GLP-1RA Sale Price by Application (2018-2023)
3 GLOBAL LONG-ACTING GLP-1RA BY COMPANY
3.1 Global Long-acting GLP-1RA Breakdown Data by Company
3.1.1 Global Long-acting GLP-1RA Annual Sales by Company (2018-2023)
3.1.2 Global Long-acting GLP-1RA Sales Market Share by Company (2018-2023)
3.2 Global Long-acting GLP-1RA Annual Revenue by Company (2018-2023)
3.2.1 Global Long-acting GLP-1RA Revenue by Company (2018-2023)
3.2.2 Global Long-acting GLP-1RA Revenue Market Share by Company (2018-2023)
3.3 Global Long-acting GLP-1RA Sale Price by Company
3.4 Key Manufacturers Long-acting GLP-1RA Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting GLP-1RA Product Location Distribution
3.4.2 Players Long-acting GLP-1RA Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LONG-ACTING GLP-1RA BY GEOGRAPHIC REGION
4.1 World Historic Long-acting GLP-1RA Market Size by Geographic Region (2018-2023)
4.1.1 Global Long-acting GLP-1RA Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Long-acting GLP-1RA Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Long-acting GLP-1RA Market Size by Country/Region (2018-2023)
4.2.1 Global Long-acting GLP-1RA Annual Sales by Country/Region (2018-2023)
4.2.2 Global Long-acting GLP-1RA Annual Revenue by Country/Region (2018-2023)
4.3 Americas Long-acting GLP-1RA Sales Growth
4.4 APAC Long-acting GLP-1RA Sales Growth
4.5 Europe Long-acting GLP-1RA Sales Growth
4.6 Middle East & Africa Long-acting GLP-1RA Sales Growth
5 AMERICAS
5.1 Americas Long-acting GLP-1RA Sales by Country
5.1.1 Americas Long-acting GLP-1RA Sales by Country (2018-2023)
5.1.2 Americas Long-acting GLP-1RA Revenue by Country (2018-2023)
5.2 Americas Long-acting GLP-1RA Sales by Type
5.3 Americas Long-acting GLP-1RA Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting GLP-1RA Sales by Region
6.1.1 APAC Long-acting GLP-1RA Sales by Region (2018-2023)
6.1.2 APAC Long-acting GLP-1RA Revenue by Region (2018-2023)
6.2 APAC Long-acting GLP-1RA Sales by Type
6.3 APAC Long-acting GLP-1RA Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting GLP-1RA by Country
7.1.1 Europe Long-acting GLP-1RA Sales by Country (2018-2023)
7.1.2 Europe Long-acting GLP-1RA Revenue by Country (2018-2023)
7.2 Europe Long-acting GLP-1RA Sales by Type
7.3 Europe Long-acting GLP-1RA Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting GLP-1RA by Country
8.1.1 Middle East & Africa Long-acting GLP-1RA Sales by Country (2018-2023)
8.1.2 Middle East & Africa Long-acting GLP-1RA Revenue by Country (2018-2023)
8.2 Middle East & Africa Long-acting GLP-1RA Sales by Type
8.3 Middle East & Africa Long-acting GLP-1RA Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting GLP-1RA
10.3 Manufacturing Process Analysis of Long-acting GLP-1RA
10.4 Industry Chain Structure of Long-acting GLP-1RA
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting GLP-1RA Distributors
11.3 Long-acting GLP-1RA Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING GLP-1RA BY GEOGRAPHIC REGION
12.1 Global Long-acting GLP-1RA Market Size Forecast by Region
12.1.1 Global Long-acting GLP-1RA Forecast by Region (2024-2029)
12.1.2 Global Long-acting GLP-1RA Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Long-acting GLP-1RA Forecast by Type
12.7 Global Long-acting GLP-1RA Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
13.1.3 Novo Nordisk Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Long-acting GLP-1RA Product Portfolios and Specifications
13.2.3 GSK Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Novo Nordisk
13.3.1 Novo Nordisk Company Information
13.3.2 Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
13.3.3 Novo Nordisk Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novo Nordisk Main Business Overview
13.3.5 Novo Nordisk Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Long-acting GLP-1RA Product Portfolios and Specifications
13.4.3 AstraZeneca Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Eli Lily
13.5.1 Eli Lily Company Information
13.5.2 Eli Lily Long-acting GLP-1RA Product Portfolios and Specifications
13.5.3 Eli Lily Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Eli Lily Main Business Overview
13.5.5 Eli Lily Latest Developments
13.6 Hansoh Pharmaceutical
13.6.1 Hansoh Pharmaceutical Company Information
13.6.2 Hansoh Pharmaceutical Long-acting GLP-1RA Product Portfolios and Specifications
13.6.3 Hansoh Pharmaceutical Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hansoh Pharmaceutical Main Business Overview
13.6.5 Hansoh Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting GLP-1RA Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Long-acting GLP-1RA by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Long-acting GLP-1RA by Country/Region, 2018, 2022 & 2029
2.2 Long-acting GLP-1RA Segment by Type
2.2.1 Liraglutide
2.2.2 Albiglutide
2.2.3 Dulaglutide
2.2.4 Semaglutide
2.2.5 Polyethylene Glycol Loxenatide
2.2.6 Exenatide Microspheres
2.3 Long-acting GLP-1RA Sales by Type
2.3.1 Global Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
2.3.2 Global Long-acting GLP-1RA Revenue and Market Share by Type (2018-2023)
2.3.3 Global Long-acting GLP-1RA Sale Price by Type (2018-2023)
2.4 Long-acting GLP-1RA Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Long-acting GLP-1RA Sales by Application
2.5.1 Global Long-acting GLP-1RA Sale Market Share by Application (2018-2023)
2.5.2 Global Long-acting GLP-1RA Revenue and Market Share by Application (2018-2023)
2.5.3 Global Long-acting GLP-1RA Sale Price by Application (2018-2023)
3 GLOBAL LONG-ACTING GLP-1RA BY COMPANY
3.1 Global Long-acting GLP-1RA Breakdown Data by Company
3.1.1 Global Long-acting GLP-1RA Annual Sales by Company (2018-2023)
3.1.2 Global Long-acting GLP-1RA Sales Market Share by Company (2018-2023)
3.2 Global Long-acting GLP-1RA Annual Revenue by Company (2018-2023)
3.2.1 Global Long-acting GLP-1RA Revenue by Company (2018-2023)
3.2.2 Global Long-acting GLP-1RA Revenue Market Share by Company (2018-2023)
3.3 Global Long-acting GLP-1RA Sale Price by Company
3.4 Key Manufacturers Long-acting GLP-1RA Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting GLP-1RA Product Location Distribution
3.4.2 Players Long-acting GLP-1RA Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LONG-ACTING GLP-1RA BY GEOGRAPHIC REGION
4.1 World Historic Long-acting GLP-1RA Market Size by Geographic Region (2018-2023)
4.1.1 Global Long-acting GLP-1RA Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Long-acting GLP-1RA Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Long-acting GLP-1RA Market Size by Country/Region (2018-2023)
4.2.1 Global Long-acting GLP-1RA Annual Sales by Country/Region (2018-2023)
4.2.2 Global Long-acting GLP-1RA Annual Revenue by Country/Region (2018-2023)
4.3 Americas Long-acting GLP-1RA Sales Growth
4.4 APAC Long-acting GLP-1RA Sales Growth
4.5 Europe Long-acting GLP-1RA Sales Growth
4.6 Middle East & Africa Long-acting GLP-1RA Sales Growth
5 AMERICAS
5.1 Americas Long-acting GLP-1RA Sales by Country
5.1.1 Americas Long-acting GLP-1RA Sales by Country (2018-2023)
5.1.2 Americas Long-acting GLP-1RA Revenue by Country (2018-2023)
5.2 Americas Long-acting GLP-1RA Sales by Type
5.3 Americas Long-acting GLP-1RA Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting GLP-1RA Sales by Region
6.1.1 APAC Long-acting GLP-1RA Sales by Region (2018-2023)
6.1.2 APAC Long-acting GLP-1RA Revenue by Region (2018-2023)
6.2 APAC Long-acting GLP-1RA Sales by Type
6.3 APAC Long-acting GLP-1RA Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting GLP-1RA by Country
7.1.1 Europe Long-acting GLP-1RA Sales by Country (2018-2023)
7.1.2 Europe Long-acting GLP-1RA Revenue by Country (2018-2023)
7.2 Europe Long-acting GLP-1RA Sales by Type
7.3 Europe Long-acting GLP-1RA Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting GLP-1RA by Country
8.1.1 Middle East & Africa Long-acting GLP-1RA Sales by Country (2018-2023)
8.1.2 Middle East & Africa Long-acting GLP-1RA Revenue by Country (2018-2023)
8.2 Middle East & Africa Long-acting GLP-1RA Sales by Type
8.3 Middle East & Africa Long-acting GLP-1RA Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting GLP-1RA
10.3 Manufacturing Process Analysis of Long-acting GLP-1RA
10.4 Industry Chain Structure of Long-acting GLP-1RA
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting GLP-1RA Distributors
11.3 Long-acting GLP-1RA Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING GLP-1RA BY GEOGRAPHIC REGION
12.1 Global Long-acting GLP-1RA Market Size Forecast by Region
12.1.1 Global Long-acting GLP-1RA Forecast by Region (2024-2029)
12.1.2 Global Long-acting GLP-1RA Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Long-acting GLP-1RA Forecast by Type
12.7 Global Long-acting GLP-1RA Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
13.1.3 Novo Nordisk Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Long-acting GLP-1RA Product Portfolios and Specifications
13.2.3 GSK Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Novo Nordisk
13.3.1 Novo Nordisk Company Information
13.3.2 Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
13.3.3 Novo Nordisk Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novo Nordisk Main Business Overview
13.3.5 Novo Nordisk Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Long-acting GLP-1RA Product Portfolios and Specifications
13.4.3 AstraZeneca Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Eli Lily
13.5.1 Eli Lily Company Information
13.5.2 Eli Lily Long-acting GLP-1RA Product Portfolios and Specifications
13.5.3 Eli Lily Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Eli Lily Main Business Overview
13.5.5 Eli Lily Latest Developments
13.6 Hansoh Pharmaceutical
13.6.1 Hansoh Pharmaceutical Company Information
13.6.2 Hansoh Pharmaceutical Long-acting GLP-1RA Product Portfolios and Specifications
13.6.3 Hansoh Pharmaceutical Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hansoh Pharmaceutical Main Business Overview
13.6.5 Hansoh Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-acting GLP-1RA Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Long-acting GLP-1RA Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Liraglutide
Table 4. Major Players of Albiglutide
Table 5. Major Players of Dulaglutide
Table 6. Major Players of Semaglutide
Table 7. Major Players of Polyethylene Glycol Loxenatide
Table 8. Major Players of Exenatide Microspheres
Table 9. Global Long-acting GLP-1RA Sales by Type (2018-2023) & (K Units)
Table 10. Global Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
Table 11. Global Long-acting GLP-1RA Revenue by Type (2018-2023) & ($ million)
Table 12. Global Long-acting GLP-1RA Revenue Market Share by Type (2018-2023)
Table 13. Global Long-acting GLP-1RA Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Long-acting GLP-1RA Sales by Application (2018-2023) & (K Units)
Table 15. Global Long-acting GLP-1RA Sales Market Share by Application (2018-2023)
Table 16. Global Long-acting GLP-1RA Revenue by Application (2018-2023)
Table 17. Global Long-acting GLP-1RA Revenue Market Share by Application (2018-2023)
Table 18. Global Long-acting GLP-1RA Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Long-acting GLP-1RA Sales by Company (2018-2023) & (K Units)
Table 20. Global Long-acting GLP-1RA Sales Market Share by Company (2018-2023)
Table 21. Global Long-acting GLP-1RA Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Long-acting GLP-1RA Revenue Market Share by Company (2018-2023)
Table 23. Global Long-acting GLP-1RA Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Long-acting GLP-1RA Producing Area Distribution and Sales Area
Table 25. Players Long-acting GLP-1RA Products Offered
Table 26. Long-acting GLP-1RA Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Long-acting GLP-1RA Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Long-acting GLP-1RA Sales Market Share Geographic Region (2018-2023)
Table 31. Global Long-acting GLP-1RA Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Long-acting GLP-1RA Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Long-acting GLP-1RA Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Long-acting GLP-1RA Sales Market Share by Country/Region (2018-2023)
Table 35. Global Long-acting GLP-1RA Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Long-acting GLP-1RA Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Long-acting GLP-1RA Sales by Country (2018-2023) & (K Units)
Table 38. Americas Long-acting GLP-1RA Sales Market Share by Country (2018-2023)
Table 39. Americas Long-acting GLP-1RA Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Long-acting GLP-1RA Revenue Market Share by Country (2018-2023)
Table 41. Americas Long-acting GLP-1RA Sales by Type (2018-2023) & (K Units)
Table 42. Americas Long-acting GLP-1RA Sales by Application (2018-2023) & (K Units)
Table 43. APAC Long-acting GLP-1RA Sales by Region (2018-2023) & (K Units)
Table 44. APAC Long-acting GLP-1RA Sales Market Share by Region (2018-2023)
Table 45. APAC Long-acting GLP-1RA Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Long-acting GLP-1RA Revenue Market Share by Region (2018-2023)
Table 47. APAC Long-acting GLP-1RA Sales by Type (2018-2023) & (K Units)
Table 48. APAC Long-acting GLP-1RA Sales by Application (2018-2023) & (K Units)
Table 49. Europe Long-acting GLP-1RA Sales by Country (2018-2023) & (K Units)
Table 50. Europe Long-acting GLP-1RA Sales Market Share by Country (2018-2023)
Table 51. Europe Long-acting GLP-1RA Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Long-acting GLP-1RA Revenue Market Share by Country (2018-2023)
Table 53. Europe Long-acting GLP-1RA Sales by Type (2018-2023) & (K Units)
Table 54. Europe Long-acting GLP-1RA Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Long-acting GLP-1RA Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Long-acting GLP-1RA Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Long-acting GLP-1RA Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Long-acting GLP-1RA Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Long-acting GLP-1RA Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Long-acting GLP-1RA
Table 62. Key Market Challenges & Risks of Long-acting GLP-1RA
Table 63. Key Industry Trends of Long-acting GLP-1RA
Table 64. Long-acting GLP-1RA Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Long-acting GLP-1RA Distributors List
Table 67. Long-acting GLP-1RA Customer List
Table 68. Global Long-acting GLP-1RA Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Long-acting GLP-1RA Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Long-acting GLP-1RA Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Long-acting GLP-1RA Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Long-acting GLP-1RA Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Long-acting GLP-1RA Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Long-acting GLP-1RA Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Long-acting GLP-1RA Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Long-acting GLP-1RA Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Long-acting GLP-1RA Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Long-acting GLP-1RA Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Long-acting GLP-1RA Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Long-acting GLP-1RA Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Long-acting GLP-1RA Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Novo Nordisk Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 83. Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
Table 84. Novo Nordisk Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Novo Nordisk Main Business
Table 86. Novo Nordisk Latest Developments
Table 87. GSK Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK Long-acting GLP-1RA Product Portfolios and Specifications
Table 89. GSK Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Novo Nordisk Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 93. Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
Table 94. Novo Nordisk Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Latest Developments
Table 97. AstraZeneca Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Long-acting GLP-1RA Product Portfolios and Specifications
Table 99. AstraZeneca Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. AstraZeneca Main Business
Table 101. AstraZeneca Latest Developments
Table 102. Eli Lily Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 103. Eli Lily Long-acting GLP-1RA Product Portfolios and Specifications
Table 104. Eli Lily Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Eli Lily Main Business
Table 106. Eli Lily Latest Developments
Table 107. Hansoh Pharmaceutical Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 108. Hansoh Pharmaceutical Long-acting GLP-1RA Product Portfolios and Specifications
Table 109. Hansoh Pharmaceutical Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Hansoh Pharmaceutical Main Business
Table 111. Hansoh Pharmaceutical Latest Developments
Table 1. Long-acting GLP-1RA Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Long-acting GLP-1RA Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Liraglutide
Table 4. Major Players of Albiglutide
Table 5. Major Players of Dulaglutide
Table 6. Major Players of Semaglutide
Table 7. Major Players of Polyethylene Glycol Loxenatide
Table 8. Major Players of Exenatide Microspheres
Table 9. Global Long-acting GLP-1RA Sales by Type (2018-2023) & (K Units)
Table 10. Global Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
Table 11. Global Long-acting GLP-1RA Revenue by Type (2018-2023) & ($ million)
Table 12. Global Long-acting GLP-1RA Revenue Market Share by Type (2018-2023)
Table 13. Global Long-acting GLP-1RA Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Long-acting GLP-1RA Sales by Application (2018-2023) & (K Units)
Table 15. Global Long-acting GLP-1RA Sales Market Share by Application (2018-2023)
Table 16. Global Long-acting GLP-1RA Revenue by Application (2018-2023)
Table 17. Global Long-acting GLP-1RA Revenue Market Share by Application (2018-2023)
Table 18. Global Long-acting GLP-1RA Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Long-acting GLP-1RA Sales by Company (2018-2023) & (K Units)
Table 20. Global Long-acting GLP-1RA Sales Market Share by Company (2018-2023)
Table 21. Global Long-acting GLP-1RA Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Long-acting GLP-1RA Revenue Market Share by Company (2018-2023)
Table 23. Global Long-acting GLP-1RA Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Long-acting GLP-1RA Producing Area Distribution and Sales Area
Table 25. Players Long-acting GLP-1RA Products Offered
Table 26. Long-acting GLP-1RA Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Long-acting GLP-1RA Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Long-acting GLP-1RA Sales Market Share Geographic Region (2018-2023)
Table 31. Global Long-acting GLP-1RA Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Long-acting GLP-1RA Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Long-acting GLP-1RA Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Long-acting GLP-1RA Sales Market Share by Country/Region (2018-2023)
Table 35. Global Long-acting GLP-1RA Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Long-acting GLP-1RA Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Long-acting GLP-1RA Sales by Country (2018-2023) & (K Units)
Table 38. Americas Long-acting GLP-1RA Sales Market Share by Country (2018-2023)
Table 39. Americas Long-acting GLP-1RA Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Long-acting GLP-1RA Revenue Market Share by Country (2018-2023)
Table 41. Americas Long-acting GLP-1RA Sales by Type (2018-2023) & (K Units)
Table 42. Americas Long-acting GLP-1RA Sales by Application (2018-2023) & (K Units)
Table 43. APAC Long-acting GLP-1RA Sales by Region (2018-2023) & (K Units)
Table 44. APAC Long-acting GLP-1RA Sales Market Share by Region (2018-2023)
Table 45. APAC Long-acting GLP-1RA Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Long-acting GLP-1RA Revenue Market Share by Region (2018-2023)
Table 47. APAC Long-acting GLP-1RA Sales by Type (2018-2023) & (K Units)
Table 48. APAC Long-acting GLP-1RA Sales by Application (2018-2023) & (K Units)
Table 49. Europe Long-acting GLP-1RA Sales by Country (2018-2023) & (K Units)
Table 50. Europe Long-acting GLP-1RA Sales Market Share by Country (2018-2023)
Table 51. Europe Long-acting GLP-1RA Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Long-acting GLP-1RA Revenue Market Share by Country (2018-2023)
Table 53. Europe Long-acting GLP-1RA Sales by Type (2018-2023) & (K Units)
Table 54. Europe Long-acting GLP-1RA Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Long-acting GLP-1RA Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Long-acting GLP-1RA Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Long-acting GLP-1RA Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Long-acting GLP-1RA Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Long-acting GLP-1RA Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Long-acting GLP-1RA
Table 62. Key Market Challenges & Risks of Long-acting GLP-1RA
Table 63. Key Industry Trends of Long-acting GLP-1RA
Table 64. Long-acting GLP-1RA Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Long-acting GLP-1RA Distributors List
Table 67. Long-acting GLP-1RA Customer List
Table 68. Global Long-acting GLP-1RA Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Long-acting GLP-1RA Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Long-acting GLP-1RA Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Long-acting GLP-1RA Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Long-acting GLP-1RA Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Long-acting GLP-1RA Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Long-acting GLP-1RA Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Long-acting GLP-1RA Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Long-acting GLP-1RA Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Long-acting GLP-1RA Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Long-acting GLP-1RA Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Long-acting GLP-1RA Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Long-acting GLP-1RA Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Long-acting GLP-1RA Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Novo Nordisk Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 83. Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
Table 84. Novo Nordisk Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Novo Nordisk Main Business
Table 86. Novo Nordisk Latest Developments
Table 87. GSK Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK Long-acting GLP-1RA Product Portfolios and Specifications
Table 89. GSK Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Novo Nordisk Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 93. Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
Table 94. Novo Nordisk Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Latest Developments
Table 97. AstraZeneca Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Long-acting GLP-1RA Product Portfolios and Specifications
Table 99. AstraZeneca Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. AstraZeneca Main Business
Table 101. AstraZeneca Latest Developments
Table 102. Eli Lily Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 103. Eli Lily Long-acting GLP-1RA Product Portfolios and Specifications
Table 104. Eli Lily Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Eli Lily Main Business
Table 106. Eli Lily Latest Developments
Table 107. Hansoh Pharmaceutical Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 108. Hansoh Pharmaceutical Long-acting GLP-1RA Product Portfolios and Specifications
Table 109. Hansoh Pharmaceutical Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Hansoh Pharmaceutical Main Business
Table 111. Hansoh Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Long-acting GLP-1RA
Figure 2. Long-acting GLP-1RA Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting GLP-1RA Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Long-acting GLP-1RA Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Long-acting GLP-1RA Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Liraglutide
Figure 10. Product Picture of Albiglutide
Figure 11. Product Picture of Dulaglutide
Figure 12. Product Picture of Semaglutide
Figure 13. Product Picture of Polyethylene Glycol Loxenatide
Figure 14. Product Picture of Exenatide Microspheres
Figure 15. Global Long-acting GLP-1RA Sales Market Share by Type in 2022
Figure 16. Global Long-acting GLP-1RA Revenue Market Share by Type (2018-2023)
Figure 17. Long-acting GLP-1RA Consumed in Hospital
Figure 18. Global Long-acting GLP-1RA Market: Hospital (2018-2023) & (K Units)
Figure 19. Long-acting GLP-1RA Consumed in Clinic
Figure 20. Global Long-acting GLP-1RA Market: Clinic (2018-2023) & (K Units)
Figure 21. Long-acting GLP-1RA Consumed in Other
Figure 22. Global Long-acting GLP-1RA Market: Other (2018-2023) & (K Units)
Figure 23. Global Long-acting GLP-1RA Sales Market Share by Application (2022)
Figure 24. Global Long-acting GLP-1RA Revenue Market Share by Application in 2022
Figure 25. Long-acting GLP-1RA Sales Market by Company in 2022 (K Units)
Figure 26. Global Long-acting GLP-1RA Sales Market Share by Company in 2022
Figure 27. Long-acting GLP-1RA Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Long-acting GLP-1RA Revenue Market Share by Company in 2022
Figure 29. Global Long-acting GLP-1RA Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Long-acting GLP-1RA Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Long-acting GLP-1RA Sales 2018-2023 (K Units)
Figure 32. Americas Long-acting GLP-1RA Revenue 2018-2023 ($ Millions)
Figure 33. APAC Long-acting GLP-1RA Sales 2018-2023 (K Units)
Figure 34. APAC Long-acting GLP-1RA Revenue 2018-2023 ($ Millions)
Figure 35. Europe Long-acting GLP-1RA Sales 2018-2023 (K Units)
Figure 36. Europe Long-acting GLP-1RA Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Long-acting GLP-1RA Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Long-acting GLP-1RA Revenue 2018-2023 ($ Millions)
Figure 39. Americas Long-acting GLP-1RA Sales Market Share by Country in 2022
Figure 40. Americas Long-acting GLP-1RA Revenue Market Share by Country in 2022
Figure 41. Americas Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
Figure 42. Americas Long-acting GLP-1RA Sales Market Share by Application (2018-2023)
Figure 43. United States Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Long-acting GLP-1RA Sales Market Share by Region in 2022
Figure 48. APAC Long-acting GLP-1RA Revenue Market Share by Regions in 2022
Figure 49. APAC Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
Figure 50. APAC Long-acting GLP-1RA Sales Market Share by Application (2018-2023)
Figure 51. China Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Long-acting GLP-1RA Sales Market Share by Country in 2022
Figure 59. Europe Long-acting GLP-1RA Revenue Market Share by Country in 2022
Figure 60. Europe Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
Figure 61. Europe Long-acting GLP-1RA Sales Market Share by Application (2018-2023)
Figure 62. Germany Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Long-acting GLP-1RA Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Application (2018-2023)
Figure 71. Egypt Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Long-acting GLP-1RA in 2022
Figure 77. Manufacturing Process Analysis of Long-acting GLP-1RA
Figure 78. Industry Chain Structure of Long-acting GLP-1RA
Figure 79. Channels of Distribution
Figure 80. Global Long-acting GLP-1RA Sales Market Forecast by Region (2024-2029)
Figure 81. Global Long-acting GLP-1RA Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Long-acting GLP-1RA Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Long-acting GLP-1RA Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Long-acting GLP-1RA Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Long-acting GLP-1RA Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Long-acting GLP-1RA
Figure 2. Long-acting GLP-1RA Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting GLP-1RA Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Long-acting GLP-1RA Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Long-acting GLP-1RA Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Liraglutide
Figure 10. Product Picture of Albiglutide
Figure 11. Product Picture of Dulaglutide
Figure 12. Product Picture of Semaglutide
Figure 13. Product Picture of Polyethylene Glycol Loxenatide
Figure 14. Product Picture of Exenatide Microspheres
Figure 15. Global Long-acting GLP-1RA Sales Market Share by Type in 2022
Figure 16. Global Long-acting GLP-1RA Revenue Market Share by Type (2018-2023)
Figure 17. Long-acting GLP-1RA Consumed in Hospital
Figure 18. Global Long-acting GLP-1RA Market: Hospital (2018-2023) & (K Units)
Figure 19. Long-acting GLP-1RA Consumed in Clinic
Figure 20. Global Long-acting GLP-1RA Market: Clinic (2018-2023) & (K Units)
Figure 21. Long-acting GLP-1RA Consumed in Other
Figure 22. Global Long-acting GLP-1RA Market: Other (2018-2023) & (K Units)
Figure 23. Global Long-acting GLP-1RA Sales Market Share by Application (2022)
Figure 24. Global Long-acting GLP-1RA Revenue Market Share by Application in 2022
Figure 25. Long-acting GLP-1RA Sales Market by Company in 2022 (K Units)
Figure 26. Global Long-acting GLP-1RA Sales Market Share by Company in 2022
Figure 27. Long-acting GLP-1RA Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Long-acting GLP-1RA Revenue Market Share by Company in 2022
Figure 29. Global Long-acting GLP-1RA Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Long-acting GLP-1RA Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Long-acting GLP-1RA Sales 2018-2023 (K Units)
Figure 32. Americas Long-acting GLP-1RA Revenue 2018-2023 ($ Millions)
Figure 33. APAC Long-acting GLP-1RA Sales 2018-2023 (K Units)
Figure 34. APAC Long-acting GLP-1RA Revenue 2018-2023 ($ Millions)
Figure 35. Europe Long-acting GLP-1RA Sales 2018-2023 (K Units)
Figure 36. Europe Long-acting GLP-1RA Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Long-acting GLP-1RA Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Long-acting GLP-1RA Revenue 2018-2023 ($ Millions)
Figure 39. Americas Long-acting GLP-1RA Sales Market Share by Country in 2022
Figure 40. Americas Long-acting GLP-1RA Revenue Market Share by Country in 2022
Figure 41. Americas Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
Figure 42. Americas Long-acting GLP-1RA Sales Market Share by Application (2018-2023)
Figure 43. United States Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Long-acting GLP-1RA Sales Market Share by Region in 2022
Figure 48. APAC Long-acting GLP-1RA Revenue Market Share by Regions in 2022
Figure 49. APAC Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
Figure 50. APAC Long-acting GLP-1RA Sales Market Share by Application (2018-2023)
Figure 51. China Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Long-acting GLP-1RA Sales Market Share by Country in 2022
Figure 59. Europe Long-acting GLP-1RA Revenue Market Share by Country in 2022
Figure 60. Europe Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
Figure 61. Europe Long-acting GLP-1RA Sales Market Share by Application (2018-2023)
Figure 62. Germany Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Long-acting GLP-1RA Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Application (2018-2023)
Figure 71. Egypt Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Long-acting GLP-1RA Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Long-acting GLP-1RA in 2022
Figure 77. Manufacturing Process Analysis of Long-acting GLP-1RA
Figure 78. Industry Chain Structure of Long-acting GLP-1RA
Figure 79. Channels of Distribution
Figure 80. Global Long-acting GLP-1RA Sales Market Forecast by Region (2024-2029)
Figure 81. Global Long-acting GLP-1RA Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Long-acting GLP-1RA Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Long-acting GLP-1RA Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Long-acting GLP-1RA Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Long-acting GLP-1RA Revenue Market Share Forecast by Application (2024-2029)
